Last reviewed · How we verify
NCT06152497
The Role of Histamine in Muscle Protein Synthesis Following Resistance Training
NA trial testing Placebo in Histamine in 50 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | University Ghent |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 50 |
| Start date | 1 September 2023 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Placebo
- H1 blockade: Telfast: 180mg Fexofenadine — full drug profile →
- Resistance training
Conditions studied
- Histamine — all drugs for Histamine →
Sponsor
University Ghent
Who can join
Adults 18 to 45, male only, with Histamine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Blocking histamine H1/H2 receptors blunts chronic endurance training adaptations. The current study addresses the following research question: "What is the influence of histamine H1 signaling on training adaptations following ten weeks of resistance training in human skeletal muscle." Results from this study will yield more insights into the molecular mechanisms of adaptations to exercise training.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06152497
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Histamine
Currently open trials in the same condition.
- NCT06328543 — Itch Sensation Induced by Multiple Applications of Pruritogens (temporal Summation) · NA · recruiting
- NCT06340438 — Investigate the Relationship Between Catastrophizing and the Perception of Itch Intensity in Healthy Individuals · NA · recruiting
- NCT06328530 — Itch Sensation Induced by Simultaneous Application of Pruritogens (Spatial Summation) · NA · recruiting
- NCT06081946 — Investigation of the Effects of Sleep Fragmentation on Itch and Pain Sensitivity · NA · recruiting
- NCT06081998 — Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity · NA · recruiting
Other University Ghent trials
Trials by the same sponsor.
- NCT07398053 — General Practitioner & Pharmacist Support for Discontinuing Long-term Antidepressants in Clinically Stable Patients · NA · not yet recruiting
- NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
- NCT07091071 — Evaluation of the CochSyn Device in Clinical Practice · NA · completed
- NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
- NCT07176156 — Evaluation of the Quality of Chat Conversations With the Suicide Helpline Zelfmoordlijn 1813 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06152497 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Ghent
- Last refreshed: 13 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06152497.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing